For help on how to get the results you want, see our search tips.
95 results
Categories
Human Remove Human filter
Medicine
Referrals Remove Referrals filter
Referral type
Article 30 referrals Remove Article 30 referrals filter
-
List item
Referral: Varilrix
live attenuated varicella virus (OKA strain), Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/02/2021, EC decision date: 21/04/2021, Last updated: 09/06/2021 -
List item
Referral: Septanest and associated names
articaine (hydrochloride), adrenaline (tartrate), Article 30 referrals
Status: European Commission final decision, opinion/position date: 28/06/2018, EC decision date: 28/03/2019, Last updated: 19/06/2019 -
List item
Referral: Scandonest and associated names
mepivacaine, associated names: Biocaine, Scandicaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 31/05/2018, EC decision date: 02/08/2018, Last updated: 07/08/2018 -
List item
Referral: Vepesid
etoposide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2017, EC decision date: 26/06/2017, Last updated: 14/07/2017 -
List item
Referral: Etopophos
etoposide phosphate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2017, EC decision date: 26/06/2017, Last updated: 14/07/2017 -
List item
Referral: Saroten and associated names
amitriptyline, associated names: Saroten Retard, Redomex, Redomex Diffucaps, Saroten Tabs, Saroten retard Tabs, Saroten 2ml, Sarotex, Sarotex Retard, Sarotex Retard 25, Sarotex Retard 50, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 08/05/2017, Last updated: 06/06/2017 -
List item
Referral: Haldol Decanoate and associated names
haloperidol decanoate, associated names: Haldol Decanoat, Haldol Decanoas, Serenase Dekanoat, Serenase Depot, Haldol - Janssen Decanoat Depot, Haldol Decanoato, Haldol Depot, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 28/04/2017, Last updated: 11/05/2017 -
List item
Referral: Haldol and associated names
haloperidol, associated names: Aloperidin, Haldol-Janssen, Serenase, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 28/04/2017, Last updated: 05/05/2017 -
List item
Referral: Lovenox and associated names
enoxaparin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/12/2016, EC decision date: 09/03/2017, Last updated: 22/03/2017 -
List item
Referral: Clenil and associated names
beclometasone dipropionate, associated names: Becloneb, Beclospin and Sanasthmax, Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/09/2016, EC decision date: 11/11/2016, Last updated: 18/11/2016 -
List item
Referral: Durogesic and associated names
fentanyl, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/07/2016, EC decision date: 22/09/2016, Last updated: 19/10/2016 -
List item
Referral: Novantrone and associated names
mitoxantrone, associated names: Elsep, Ralenova, Article 30 referrals
Status: European Commission final decision, opinion/position date: 28/04/2016, EC decision date: 24/06/2016, Last updated: 05/07/2016 -
List item
Referral: Cymevene
ganciclovir, associated names: Cymevan, Citovirax, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 28/04/2016, Last updated: 21/06/2016 -
List item
Referral: Amoxil
amoxicillin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/06/2015, EC decision date: 20/08/2015, Last updated: 19/05/2016 -
List item
Referral: Ikorel and Dancor
nicorandil, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/03/2015, EC decision date: 05/06/2015, Last updated: 30/06/2015 -
List item
Referral: Plendil and associated names
felodipine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 16/12/2014, Last updated: 30/03/2015 -
List item
Referral: Nasonex
mometasone furoate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 19/01/2015, Last updated: 03/02/2015 -
List item
Referral: EMLA cream and associated names
lidocaine, prilocaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/09/2014, EC decision date: 28/11/2014, Last updated: 15/01/2015 -
List item
Referral: Seroquel / Seroquel XR and associated names
quetiapine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 06/08/2014, Last updated: 09/09/2014 -
List item
Referral: Sandostatin LAR and associated names
ocreotide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2014, EC decision date: 26/06/2014, Last updated: 27/06/2014 -
List item
Referral: Sandostatin and associated names
ocreotide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2014, EC decision date: 26/06/2014, Last updated: 27/06/2014 -
List item
Referral: Rocephin
Ceftriaxone, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/01/2014, EC decision date: 21/03/2014, Last updated: 19/05/2014 -
List item
Referral: Valtrex
valaciclovir, associated names: Zelitrex, Talavir, Valaciclovir Allen, Valherpes, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 13/07/2010, Last updated: 25/03/2014 -
List item
Referral: Targocid and associated names
teicoplanin, associated names: Targocid, Teicomid, Article 30 referrals
Status: European Commission final decision, opinion/position date: 30/05/2013, EC decision date: 12/09/2013, Last updated: 03/01/2014 -
List item
Referral: Sandimmun and associated names
ciclosporin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 27/06/2013, EC decision date: 31/10/2013, Last updated: 20/12/2013